|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.830 USD | +0.52% |
|
-13.35% | -29.96% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 7.36M 6.46M 6.01M 5.52M 10.36M 709M 10.52M 71.38M 27.89M 348M 27.63M 27.03M 1.2B | P/E 2026 * |
-0.02x | P/E 2027 * | -0.02x |
|---|---|---|---|---|---|
| Enterprise Value | 7.36M 6.46M 6.01M 5.52M 10.36M 709M 10.52M 71.38M 27.89M 348M 27.63M 27.03M 1.2B | EV / Sales 2026 * |
4.88x | EV / Sales 2027 * | 2.1x |
| Free-Float |
96.53% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.52% | ||
| 1 week | -13.35% | ||
| Current month | -0.52% | ||
| 1 month | -9.24% | ||
| 3 months | -20.70% | ||
| 6 months | -42.66% | ||
| Current year | -29.96% |
| 1 week | 3.78 |  | 4.5 |
| 1 month | 3.78 | | 4.5 |
| Current year | 3.75 | | 7.2 |
| 1 year | 3.75 | | 7.2 |
| 3 years | 3.75 | | 31.2 |
| 5 years | 3.75 | | 385.7 |
| 10 years | 3.75 | | 861.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Alonso
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-14 |
William Quinn
CEO | Chief Executive Officer | 55 | 2024-05-14 |
Grant Yonehiro
COO | Chief Operating Officer | 61 | 2024-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Kathleen LaPorte
BRD | Director/Board Member | 64 | 2020-11-30 |
William Quinn
BRD | Director/Board Member | 55 | 2024-05-14 |
| Chairman | 56 | 2024-09-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/10/26 | Free | Chairman | 5,000 | 0.2602% | ||
| 6/10/26 | Free | Director | 5,000 | 0.2602% | ||
| 6/10/26 | Free | Director | 5,000 | 0.2602% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | -13.35% | -41.97% | -85.81% | 7.32M | |
| +0.93% | +6.97% | +62.83% | +67.97% | 56.67B | |
| -1.92% | +6.03% | +43.68% | +84.56% | 55.92B | |
| -0.46% | -1.29% | +3.28% | +422.58% | 23.28B | |
| -2.97% | -2.35% | -22.03% | -16.54% | 23.28B | |
| -0.36% | +5.73% | +30.99% | -3.58% | 20.54B | |
| -1.34% | +0.51% | +25.02% | -30.27% | 17.78B | |
| -1.44% | +5.67% | +32.54% | +544.11% | 15.9B | |
| -1.30% | -5.02% | +165.62% | +291.37% | 14.64B | |
| -0.50% | -0.98% | +23.62% | +178.38% | 13.99B | |
| Average | -0.88% | -1.34% | +32.36% | +145.28% | 24.2B | |
| Weighted average by Cap. | -0.89% | +1.19% | +40.99% | +135.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.51M 1.33M 1.23M 1.13M 2.12M 145M 2.16M 14.63M 5.72M 71.43M 5.66M 5.54M 247M | 3.5M 3.07M 2.86M 2.62M 4.93M 337M 5M 33.95M 13.26M 166M 13.14M 12.86M 573M |
| Net income | -44.52M -39.1M -36.36M -33.37M -62.7M -4.29B -63.67M -432M -169M -2.11B -167M -164M -7.29B | -47.5M -41.72M -38.8M -35.6M -66.89M -4.57B -67.92M -461M -180M -2.25B -178M -174M -7.78B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$3.830 | +0.52% | 4,175 |
| 26-07-23 | US$3.810 | -6.85% | 32,772 |
| 26-07-22 | US$4.090 | +1.74% | 4,087 |
| 26-07-21 | US$4.020 | -10.17% | 13,667 |
| 26-07-20 | US$4.475 | +1.24% | 20,724 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BOLT Stock
Select your edition
All financial news and data tailored to specific country editions
